Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Y Quan, Q Yan, JE Morales… - Stem cells …, 2015 - academic.oup.com
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
Targeted Disruption of the β 2‐Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Q Yuan, Q Yan, JE Morales… - Stem Cells …, 2015 - search.proquest.com
It was hypothesized that transplanting human embryonic stem cells (hESCs) lacking human
leukocyte antigen class I (HLA‐I) expression would not result in a robust immune rejection …
leukocyte antigen class I (HLA‐I) expression would not result in a robust immune rejection …
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Y Quan, Q Yan… - Stem cells …, 2015 - pubmed.ncbi.nlm.nih.gov
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
D Wang, Y Quan, Q Yan, JE Morales… - Stem Cells Translational …, 2015 - europepmc.org
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
Targeted Disruption of the β2‐Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Y Quan, Q Yan, JE Morales… - STEM CELLS …, 2015 - Wiley Online Library
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
[PDF][PDF] Targeted Disruption of the b2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D WANG, Y QUAN, Q YAN, JE MORALES… - MEDICINE, 2015 - researchgate.net
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Y Quan, Q Yan, JE Morales… - Stem Cells Translational …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> Human embryonic stem
cells (hESCs) are a promising source of cells for tissue regeneration, yet histoincompatibility …
cells (hESCs) are a promising source of cells for tissue regeneration, yet histoincompatibility …
[HTML][HTML] Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
D Wang, Y Quan, Q Yan, JE Morales… - Stem Cells …, 2015 - ncbi.nlm.nih.gov
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
D Wang, Y Quan, Q Yan, JE Morales… - Stem Cells Translational …, 2015 - europepmc.org
Human embryonic stem cells (hESCs) are a promising source of cells for tissue
regeneration, yet histoincompatibility remains a major challenge to their clinical application …
regeneration, yet histoincompatibility remains a major challenge to their clinical application …